The nasal-spray flu vaccine may spare children the distress of an injection, but current evidence does not show it protects better than the standard jab and eligibility restrictions still apply.
As Taiwan begins its publicly funded flu vaccination campaign, the nasal-spray option has drawn fresh attention from parents of young children who dread injections. In a Facebook post, obstetrician Su Yi-ning said many people ask whether the spray is better than the usual jab, and his answer was no: current evidence does not show that the nasal vaccine offers clearly stronger overall protection than the standard shot. He also argued that, for children who meet the eligibility rules, there is no clear evidence that it performs worse either.
The vaccine in question is a live attenuated influenza vaccine, usually shortened to LAIV. Rather than being injected into a muscle, it is sprayed into the nose, where it can trigger an immune response at the site where flu viruses often enter the body. The idea is appealing because it avoids needles and may be easier to give to children who are frightened or distressed by injections. Even so, the CDC says children should receive one of the influenza vaccines that is suitable for their age and health status, rather than assuming one form is universally superior.
In the United States, the CDC says the nasal spray vaccine is approved for healthy people aged 2 through 49, while Mayo Clinic notes that children aged 2 and older may receive it if they are otherwise suitable candidates. Both the CDC and Mayo Clinic caution that it is not for everyone. It should not be used by pregnant women, people with weakened immune systems, or children and teenagers with certain conditions, including severe immune deficiency. The CDC also says children aged 2 to 4 with asthma, or who have wheezed in the past 12 months, should not receive it.
Taiwan’s disease control authorities list similar restrictions. They warn against use in people who have had a severe allergic reaction to the vaccine or any of its ingredients, including egg proteins, and in children and teenagers under 17 who are taking aspirin or salicylate medicines because of the risk of Reye syndrome. The vaccine is also not recommended for those with serious immune disorders, including certain blood cancers, symptomatic HIV infection, cellular immune deficiencies, or people receiving high-dose steroids or immunosuppressive treatment.
The practical advantage, Su said, is simple: no needle. For families who struggle through each vaccination with a crying, resisting child, that can make a meaningful difference. But the broader public-health message remains unchanged. Flu vaccination is still recommended for children, who face a higher risk of serious complications than healthy adults, and the best choice is the vaccine a child can safely receive.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
